doxorubicin hydrochloride has been researched along with Neoplasms in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 23 (69.70) | 24.3611 |
| 2020's | 10 (30.30) | 2.80 |
| Authors | Studies |
|---|---|
| Jahng, Y; Jung, MJ; Karki, R; Kwon, Y; Lee, ES; Na, Y; Nam, JM; Thapa, P; Thapa, U | 1 |
| Cho, HJ; Jung, MJ; Kim, J; Kwon, Y; Lee, ES; Na, Y; Woo, S | 1 |
| Agrawal, SK; Rani, R; Roy, P; Saxena, AK; Singh, J; Sondhi, SM | 1 |
| Kamiie, K; Kidachi, Y; Noshita, T; Ryoyama, K; Umetsu, H; Yamaguchi, H; Yu, T | 1 |
| Li, J; Wu, X; Zhang, D | 1 |
| Kamal, A; Kumar, BA; Kumar, MS; Shankaraiah, N; Suresh, P | 1 |
| Cao, R; Chen, Z; Fan, W; Guo, L; Ma, Q; Shi, B; Song, H; Sun, J | 1 |
| Gerasimova, Ts; Iliev, I; Kraicheva, I; Kril, A; Tashev, E; Topashka-Ancheva, M; Tosheva, T; Troev, K; Tsacheva, I; Vodenicharova, E | 1 |
| Hua, WY; Shi, LY; Tang, Y; Wang, K; Wu, JQ; Wu, XM; Wu, YC; Zeng, YF; Zhang, DY; Zhou, B | 1 |
| Jee, JG; Jun, KY; Kadayat, TM; Karki, R; Kwon, Y; Lee, ES; Lee, JH; Park, C; Thapa, P | 1 |
| Cheng, K; Gao, P; Li, H; Liao, W; Sun, Q; Wang, X; Xu, G; Zeng, L; Zhang, J | 1 |
| Chen, Y; Ding, YH; Gao, X; Kuang, BJ; Long, J; Zhang, Q | 1 |
| Cui, J; Dai, Y; Huang, W; Liu, B; Pan, M; Qian, H; Qiu, Q; Shi, W; Wu, Y | 1 |
| Arthur, G; Idowu, T; Ogunsina, M; Samadder, P; Schweizer, F | 1 |
| Cui, J; Dai, Y; Huang, W; Li, Z; Pan, M; Qian, H; Qiu, Q; Shi, W; Zhang, B | 1 |
| Ding, J; Han, G; Liu, Y; Meng, C; Meng, LH; Qing, L; Shi, J; Wang, Q; Wang, Y; Wang, Z; Yang, Y | 1 |
| Bist, G; Kwon, Y; Lee, ES; Park, S; Shrestha, A; Song, C; Thapa Magar, TB | 1 |
| Kumar, K; Kumar, S; Kumar, V; Singh, A | 1 |
| Bist, G; Kadayat, TM; Kwon, Y; Lee, ES; Lee, HJ; Park, S; Shrestha, A; Thapa Magar, TB | 1 |
| Chen, J; Feng, D; Gu, X; Jiang, Y; Li, C; Qu, Y; Yin, X | 1 |
| Kharkar, PS; Shah, CP | 1 |
| Cai, B; Cui, CB; Li, CW; Wang, N; Xu, LL; Zhu, HJ | 1 |
| Bi, Y; Li, W; Ma, C; Shuai, W; Sun, H; Xu, F; Xu, J; Xu, S; Yao, H; Zhu, Z | 1 |
| Dhiman, N; Jaitak, V; Kaur, K | 1 |
| Ji, A; Li, L; Li, X; Liu, J; Liu, Z; Lou, H; Qian, L; Qiao, Y; Sun, Y; Wang, X; Xu, Y; Zhao, X | 1 |
| Cheng, K; Fang, Y; Hua, H; Ji, B; Li, D; Li, H; Li, Z; Wu, B; Zheng, C | 1 |
| Chen, ZS; Li, W; Liu, Y; Shuai, W; Tan, Y; Xu, J; Xu, S; Yang, DH; Yang, L; Yao, H; Zheng, T; Zhu, H; Zhu, Z | 1 |
| Aaghaz, S; Jain, R; Kamal, A; Sharma, K | 1 |
| Chen, G; Huang, G; Zhou, S | 1 |
| Bai, P; Chen, L; Fu, S; Han, K; He, W; Li, J; Li, Y; Liu, J; Liu, Y; Shi, M; Tang, M; Xie, L; Yan, W; Yang, J; Yang, Z; Ye, H; Zhang, C; Zhu, Z | 1 |
| Cai, Z; Ghaleb, H; Huang, W; Jiang, Y; Liu, Y; Qian, H; Qiu, Q; Shi, W; Yin, Z; Zhang, P; Zhou, J; Zou, F | 1 |
| Li, X; Lin, H; OuYang, F; Pang, Y; Yan, J; Zhang, W; Zhou, J | 1 |
| Valipour, M | 1 |
6 review(s) available for doxorubicin hydrochloride and Neoplasms
| Article | Year |
|---|---|
Recent insights into synthetic β-carbolines with anti-cancer activities.
Topics: Animals; Antineoplastic Agents; Carbolines; Chemistry Techniques, Synthetic; Drug Discovery; Humans; Neoplasms; Structure-Activity Relationship | 2017 |
Tetrazoles as anticancer agents: A review on synthetic strategies, mechanism of action and SAR studies.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Molecular Structure; Neoplasms; Structure-Activity Relationship; Tetrazoles | 2020 |
Renieramycin-type alkaloids from marine-derived organisms: Synthetic chemistry, biological activity and structural modification.
Topics: Alkaloids; Anti-Infective Agents; Antibiotics, Antineoplastic; Antiprotozoal Agents; Biological Products; Molecular Structure; Neoplasms; Tetrahydroisoquinolines | 2021 |
β-Carbolines as potential anticancer agents.
Topics: Antineoplastic Agents; Carbolines; Cyclin-Dependent Kinases; DNA Topoisomerases; Humans; Intercalating Agents; Neoplasms; Plants; Proto-Oncogene Proteins B-raf; Tubulin | 2021 |
Synthesis and anti-tumor activity of marine alkaloids.
Topics: Alkaloids; Antineoplastic Agents; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Neoplasms | 2021 |
Recent advances of antitumor shikonin/alkannin derivatives: A comprehensive overview focusing on structural classification, synthetic approaches, and mechanisms of action.
Topics: Antineoplastic Agents; Apoptosis; Humans; Naphthoquinones; Neoplasms | 2022 |
27 other study(ies) available for doxorubicin hydrochloride and Neoplasms
| Article | Year |
|---|---|
2-Thienyl-4-furyl-6-aryl pyridine derivatives: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Neoplasms; Pyrimidines; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2010 |
New benzoxanthone derivatives as topoisomerase inhibitors and DNA cross-linkers.
Topics: Antineoplastic Agents; Benzene Derivatives; Cell Line, Tumor; Cell Proliferation; DNA; DNA Topoisomerases; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Neoplasms; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Topoisomerase Inhibitors; Xanthones | 2010 |
Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Benzimidazoles; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Microwaves; Neoplasms; Ovarian Neoplasms | 2010 |
Novel effects of glycyrrhetinic acid on the central nervous system tumorigenic progenitor cells: induction of actin disruption and tumor cell-selective toxicity.
Topics: Actins; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Central Nervous System; Genes, myc; Genes, ras; Glycyrrhetinic Acid; Humans; Mice; Neoplasms; Stem Cells; Transfection | 2010 |
Synthesis and biological evaluation of novel exo-methylene cyclopentanone tetracyclic diterpenoids as antitumor agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cyclopentanes; Diterpenes; Diterpenes, Kaurane; Drug Screening Assays, Antitumor; Humans; Neoplasms | 2011 |
An efficient one-pot synthesis of benzothiazolo-4β-anilino-podophyllotoxin congeners: DNA topoisomerase-II inhibition and anticancer activity.
Topics: Antineoplastic Agents; Benzothiazoles; Cell Line, Tumor; Chlorides; DNA Topoisomerases, Type II; Halogenation; Humans; Neoplasms; Podophyllotoxin; Topoisomerase II Inhibitors; Zirconium | 2011 |
Synthesis and biological evaluation of 1,9-disubstituted β-carbolines as potent DNA intercalating and cytotoxic agents.
Topics: Antineoplastic Agents; Carbolines; Cell Line, Tumor; Cytotoxins; DNA; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Intercalating Agents; Neoplasms | 2011 |
Synthesis, antiproliferative activity and genotoxicity of novel anthracene-containing aminophosphonates and a new anthracene-derived Schiff base.
Topics: Animals; Anthracenes; Antineoplastic Agents; Cell Line; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Mice; Neoplasms; Organophosphonates; Schiff Bases | 2012 |
Synthesis and evaluation of cytotoxic effects of novel α-methylenelactone tetracyclic diterpenoids.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Diterpenes; Humans; Lactones; Neoplasms; Structure-Activity Relationship | 2012 |
Synthesis, antitumor activity, and structure-activity relationship study of trihydroxylated 2,4,6-triphenyl pyridines as potent and selective topoisomerase II inhibitors.
Topics: Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HEK293 Cells; Humans; Molecular Docking Simulation; Molecular Structure; Neoplasms; Phenols; Pyridines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2014 |
Synthesis and biological evaluation of a novel class of coumarin derivatives.
Topics: Animals; Antineoplastic Agents; Cattle; Cell Line, Tumor; Cell Survival; Circular Dichroism; Coumarins; DNA; Doxorubicin; Humans; Mice; Neoplasms; Transplantation, Heterologous | 2014 |
Dispirocyclopropyldehydrocostus lactone selectively inhibits acute myelogenous leukemia cells.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Humans; Lactones; Leukemia, Myeloid, Acute; Mice; Mice, SCID; Neoplasms; Poly(ADP-ribose) Polymerases; Prodrugs; Sesquiterpenes; Transplantation, Heterologous; Up-Regulation | 2016 |
Design, synthesis and biological evaluation of LBM-A5 derivatives as potent P-glycoprotein-mediated multidrug resistance inhibitors.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Click Chemistry; Doxorubicin; Drug Design; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; K562 Cells; Neoplasms; Structure-Activity Relationship; Tetrahydroisoquinolines | 2016 |
Replacing d-Glucosamine with Its l-Enantiomer in Glycosylated Antitumor Ether Lipids (GAELs) Retains Cytotoxic Effects against Epithelial Cancer Cells and Cancer Stem Cells.
Topics: Epithelium; Glucosamine; Glycosylation; Humans; Neoplasms; Neoplastic Stem Cells; Stereoisomerism | 2017 |
Exploration of 2-((Pyridin-4-ylmethyl)amino)nicotinamide Derivatives as Potent Reversal Agents against P-Glycoprotein-Mediated Multidrug Resistance.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP3A; Doxorubicin; Drug Discovery; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; K562 Cells; Neoplasms; Niacinamide | 2017 |
6-OH-Phenanthroquinolizidine Alkaloid and Its Derivatives Exert Potent Anticancer Activity by Delaying S Phase Progression.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Humans; Neoplasms; Phenanthrolines; Quinolizines; S Phase | 2017 |
Dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines: Topoisomerase I and IIα dual inhibitors with DNA non-intercalative catalytic activity.
Topics: Antineoplastic Agents; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type I; Halogenation; Humans; Neoplasms; Pyridines; Topoisomerase II Inhibitors | 2017 |
2-Chlorophenyl-substituted benzofuro[3,2-b]pyridines with enhanced topoisomerase inhibitory activity: The role of the chlorine substituent.
Topics: Antineoplastic Agents; Benzofurans; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Halogenation; Humans; Neoplasms; Pyridines; Topoisomerase Inhibitors | 2017 |
Synthesis and biological evaluation of bifendate derivatives bearing 6,7-dihydro-dibenzo[c,e]azepine scaffold as potential P-glycoprotein and tumor metastasis inhibitors.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azepines; Biphenyl Compounds; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; K562 Cells; Molecular Structure; Neoplasms; Structure-Activity Relationship | 2018 |
Discovery of novel human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.
Topics: Animals; Antineoplastic Agents; Benzene Derivatives; Cell Line, Tumor; Cell Survival; Drug Discovery; Enzyme Inhibitors; Humans; IMP Dehydrogenase; Mice; Molecular Docking Simulation; Neoplasms; NIH 3T3 Cells; Small Molecule Libraries; Structure-Activity Relationship | 2018 |
Four new antitumor metabolites isolated from a mutant 3-f-31 strain derived from Penicillium purpurogenum G59.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biological Products; Cell Line, Tumor; HCT116 Cells; Humans; Mice; Models, Molecular; Mutation; Neoplasms; Penicillium | 2018 |
Design, synthesis and biological evaluation of quinoline-indole derivatives as anti-tubulin agents targeting the colchicine binding site.
Topics: Animals; Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Colchicine; Drug Design; Drug Screening Assays, Antitumor; Heterografts; Humans; Indoles; K562 Cells; Neoplasms; Quinolines; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2019 |
Discovery of lysosome-targeted covalent anticancer agents based on isosteviol skeleton.
Topics: A549 Cells; Antineoplastic Agents; Cell Death; Diterpenes, Kaurane; Drug Design; Humans; Lysosomes; Neoplasms | 2021 |
Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Binding Sites; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Colchicine; Drug Design; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Inbred ICR; Molecular Docking Simulation; Neoplasms; Neovascularization, Physiologic; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2021 |
Structure-Based Design and Synthesis of N-Substituted 3-Amino-β-Carboline Derivatives as Potent αβ-Tubulin Degradation Agents.
Topics: Animals; Antineoplastic Agents; Apoptosis; Binding Sites; Carbolines; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; G2 Phase Cell Cycle Checkpoints; Humans; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms; Protein Binding; Rats; Structure-Activity Relationship; Tubulin; Tubulin Modulators; Xenograft Model Antitumor Assays | 2022 |
Exploration of novel phthalazinone derivatives as potential efflux transporter inhibitors for reversing multidrug resistance and improving the oral absorption of paclitaxel.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Neoplasm Proteins; Neoplasms; Paclitaxel | 2022 |
Discovery of a Novel Stilbene Derivative as a Microtubule Targeting Agent Capable of Inducing Cell Ferroptosis.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Ferroptosis; Humans; Microtubules; Neoplasms; Stilbenes | 2022 |